962 related articles for article (PubMed ID: 18463448)
1. Calcipotriol plus betamethasone dipropionate scalp formulation is effective and well tolerated in the treatment of scalp psoriasis: a phase II study.
Buckley C; Hoffmann V; Shapiro J; Saari S; Cambazard F; Milsgaard M
Dermatology; 2008; 217(2):107-13. PubMed ID: 18463448
[TBL] [Abstract][Full Text] [Related]
2. A new scalp formulation of calcipotriol plus betamethasone dipropionate compared with each of its active ingredients in the same vehicle for the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
van de Kerkhof PC; Hoffmann V; Anstey A; Barnes L; Bolduc C; Reich K; Saari S; Segaert S; Vaillant L
Br J Dermatol; 2009 Jan; 160(1):170-6. PubMed ID: 19067709
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
Ortonne JP; Ganslandt C; Tan J; Nordin P; Kragballe K; Segaert S
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):919-26. PubMed ID: 19453810
[TBL] [Abstract][Full Text] [Related]
5. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
[TBL] [Abstract][Full Text] [Related]
6. Treatments for scalp psoriasis with emphasis on calcipotriol plus betamethasone dipropionate gel (Xamiol).
Guenther LC
Skin Therapy Lett; 2009 May; 14(4):1-4. PubMed ID: 19585059
[TBL] [Abstract][Full Text] [Related]
7. Calcipotriol plus betamethasone dipropionate gel compared with its active components in the same vehicle and the vehicle alone in the treatment of psoriasis vulgaris: a randomised, parallel group, double-blind, exploratory study.
Fleming C; Ganslandt C; Guenther L; Johannesson A; Buckley C; Simon JC; Stegmann H; Vestergaard Tingleff L
Eur J Dermatol; 2010; 20(4):465-71. PubMed ID: 20413372
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial.
Ortonne JP; Kaufmann R; Lecha M; Goodfield M
Dermatology; 2004; 209(4):308-13. PubMed ID: 15539894
[TBL] [Abstract][Full Text] [Related]
10. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
van de Kerkhof PC
Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355
[TBL] [Abstract][Full Text] [Related]
11. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
Kragballe K; Austad J; Barnes L; Bibby A; de la Brassinne M; Cambazard F; Fleming C; Heikkilä H; Jolliffe D; Peyri J; Svensson A; Toole J; Wozel G
Br J Dermatol; 2006 Jun; 154(6):1155-60. PubMed ID: 16704648
[TBL] [Abstract][Full Text] [Related]
12. Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion.
Duweb GA; Abuzariba O; Rahim M; al-Taweel M; Abdulla SA
Int J Clin Pharmacol Res; 2000; 20(3-4):65-8. PubMed ID: 11314240
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland.
Affleck AG; Bottomley JM; Auland M; Jackson P; Ryttov J
Curr Med Res Opin; 2011 Jan; 27(1):269-84. PubMed ID: 21142836
[TBL] [Abstract][Full Text] [Related]
14. Treatment of scalp psoriasis with betamethasone dipropionate and calcipotriol two-compound product.
Cassano N; Vena GA
Acta Derm Venereol; 2007; 87(1):85-6. PubMed ID: 17225026
[No Abstract] [Full Text] [Related]
15. Significant one week efficacy of a calcipotriol plus betamethasone dipropionate scalp formulation.
Jemec GB; van de Kerkhof PC; Enevold A; Ganslandt C
J Eur Acad Dermatol Venereol; 2011 Jan; 25(1):27-32. PubMed ID: 20456557
[TBL] [Abstract][Full Text] [Related]
16. Efficacy results of a 52-week, randomised, double-blind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris.
Kragballe K; Austad J; Barnes L; Bibby A; de la Brassinne M; Cambazard F; Fleming C; Heikkilä H; Williams Z; Peyri Rey J; Svensson A; Toole J; Wozel G
Dermatology; 2006; 213(4):319-26. PubMed ID: 17135738
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
Molin L; Cutler TP; Helander I; Nyfors B; Downes N
Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
[TBL] [Abstract][Full Text] [Related]
18. Calcipotriol plus betamethasone dipropionate gel compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized, controlled trial investigating efficacy and safety in a Chinese population.
Ma L; Yang Q; Yang H; Wang G; Zheng M; Hao F; Gu J; Sun Q; Cui P; Ge M; Li R; Gao T; Facy P; Kurvits M; Xu Z; Xu J
Int J Dermatol; 2016 Jan; 55(1):106-13. PubMed ID: 26094549
[TBL] [Abstract][Full Text] [Related]
19. A two-compound product containing calcipotriol and betamethasone dipropionate provides rapid, effective treatment of psoriasis vulgaris regardless of baseline disease severity.
van de Kerkhof PC; Wasel N; Kragballe K; Cambazard F; Murray S
Dermatology; 2005; 210(4):294-9. PubMed ID: 15942215
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgaris.
Peeters P; Ortonne JP; Sitbon R; Guignard E
Dermatology; 2005; 211(2):139-45. PubMed ID: 16088161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
